Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Document Quarterly Report Document Transition Report Entity Interactive Data Current CONDENSED CONSOLIDATED BALANCE SHEETS ASSETS Current assets Cash and cash equivalents Prepaid expenses Other current assets Total current assets [Assets, Current] Other assets Total assets [Assets] LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable Accrued liabilities Note payable Total current liabilities [Liabilities, Current] Total liabilities [Liabilities] Commitments and contingencies; see Note 6 Stockholders' equity Preferred stock, undesignated, authorized 4,818,654 shares; See Note 7 Series A Preferred stock, par value $0.0001, authorized 5,181,346 shares; issued and outstanding 210, as of September 30, 2024 and December 31, 2023, respectively Common stock, par value $0.0001 per share; authorized 400,000,000 shares; issued and outstanding 3,408,906 as of September 30, 2024 and 298,281 as of December 31, 2023, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity [Equity, Attributable to Parent] Total liabilities and stockholders' equity [Liabilities and Equity] Statement [Table] Statement [Line Items] Class of Stock [Axis] Series A Preferred Stock [Member] Common Stock, Par Value Common Stock, Shares Authorized Common Stock, Shares Issued Common Stock, Shares Outstanding Preferred Stock, Undesignated Shares Authorized Preferred Stock, Par Value Preferred Stock, Shares Authorized Prefered Stock, Shares Issued Prefered Stock ,Shares Outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Operating expenses General and administrative Research and development Total operating expenses [Operating Expenses] Net operating loss [Operating Income (Loss)] Interest expense Interest income Other expense (income), net Net loss [Net Income (Loss) Attributable to Parent] Net loss per share, basic and diluted Weighted average number of common shares and prefunded warrants outstanding, basic and diluted CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (Unaudited) Equity Components [Axis] Preferred Stock Common Stock Additional Paid-In Capital Accumulated Deficit Balance, shares [Shares, Issued] Balance, amount Public offering sale of common stock, warrants, and prefunded warrants, shares Public offering sale of common stock, warrants, and prefunded warrants, amount Offering costs Exercise of pre-funded warrants for cash, shares Exercise of pre-funded warrants for cash, amount Exercise of pre-funded warrants, cashless, shares Exercise of pre-funded warrants, cashless, amount Exercise of warrants, cashless, shares Exercise of warrants, cashless, amount Stock split and fractional shares issued, shares Stock split and fractional shares issued, amount Compensation on options issued Net loss Public offering sale of common stock, warrants, and prefunded warrants, net, shares Public offering sale of common stock, warrants, and prefunded warrants, net, amount Balance, shares Balance, amount CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) CASH FLOWS FROM OPERATING ACTIVITIES Net Loss Adjustments to reconcile net loss to net cash used in operating activities Depreciation and amortization Interest on debt instrument Gain on sale of equipment [Gain (Loss) on Disposition of Property Plant Equipment] Issuance and vesting of compensatory stock options and warrants Changes in operating assets and liabilities Accounts receivable, prepaid expenses and other assets [Increase (Decrease) in Accounts Receivable and Other Operating Assets] Accounts payable and accrued liabilities Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] CASH FLOWS FROM INVESTING ACTIVITIES Proceeds from sale of property and equipment Net cash provided by investing activities [Net Cash Provided by (Used in) Investing Activities] CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from issuance of common stock, warrants, and pre-funded warrants, net of offering costs Proceeds from the exercise of warrants Payments on short-term note [Repayments of Notes Payable] Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net change in cash and cash equivalents [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental Disclosures: Cash paid for interest Cash paid for income taxes Non-cash financing activity Cashless exercise of warrants and prefunded warrants DESCRIPTION OF BUSINESS DESCRIPTION OF BUSINESS Business Description and Basis of Presentation [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] BALANCE SHEET COMPONENTS BALANCE SHEET COMPONENTS Supplemental Balance Sheet Disclosures [Text Block] NOTE PAYABLE NOTE PAYABLE Debt Disclosure [Text Block] LEASE LEASE Leases of Lessee Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] STOCKHOLDERS EQUITY STOCKHOLDERS' EQUITY SUBSEQUENT EVENTS SUBSEQUENT EVENTS Subsequent Events [Text Block] Basis of Presentation Use Of Estimates Principles Of Consolidation Reverse Stock Splits Cash And Cash Equivalents Cash Concentration Risk Liquidity And Capital Resources Stock-Based Compensation Equity-Based Payments to Non-Employees Warrants for Common Shares and Derivative Financial Instruments Loss Per Share Anti-dilutive Securities Accrued Liabilities Plan Name Axis 2022 Stock Incentive Plan [Member] 2022 Plan Stock Options [Member] 2016 Plan Stock Options [Member] 1999 Plan Stock Options [Member] Schedule of Warrants Activity Schedule of Black-Scholes Option Pricing model Summarizes shares available for grant Schedule of outstanding stock options Title of Individual [Axis] 2024 Private Placement [Member] Accumulated Deficit [Cumulative Earnings (Deficit)] Cash and cash equivalents [Cash and Cash Equivalents, at Carrying Value] Description of private placement Class Of Warrant Or Right Axis Warrants To Purchase Common Stock [Member] Options To Purchase Common Stock [Member] Covertible Preferred Shares Outstanding [Member] Anti- Securities Dilutive Related Party Transactions By Related Party Axis Intra Fi Network [Member] Cash uninsured amount Federal Deposit Insurance Corporation insurance limits Total current assets [Capital Lease Obligations, Current] Working capital amount Cash resources Deposits Operating Costs Employee Related Total [Accounts Payable and Accrued Liabilities, Current] Depreciation expense Note Payable Related party Interest expense [Interest expense] Proceeds from issuance of note payable Interest rate on notes payable Note payable downpayment Monthly installment Lease Expense Annual Base Rent Increased Monthly rent installment Description of lease term Percentage of Annual Increase in Rent Simdax License Agreement [Member] Grant paid to canadian authority Grant paid to authority Non-refundable commercialization milestone payment Warrants outstanding beginning [Class of Warrant or Right, Outstanding] Warrants issued Warrants Exercised Warrants outstanding ending Warrants,Weighted average exercise price beginning [Class of Warrant or Right, Exercise Price of Warrants or Rights] Weighted average exercise price, issued Weighted average exercise price, excercised Warrants, weighted average exercise price, ending Remaining contractual term Risk free interest rate Expected dividends Expected Volatility February 2023 Warrants [Member] February 2024 Warrants [Member] Remaining contractual term Risk free interest rate Expected dividends Expected Volatility Options, beginning balance Additional Shares reserved Options cancelled/forfeited Options granted [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures] Options, ending balance Number of shares, Options Outstanding, Beginning [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number] Number of shares, Options Outstanding, cancelled/forfeited [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period] Number of shares, Options Outstanding, granted Number of shares, Options Outstanding, Ending Weighted average exercise price, option outstanding, Beginning Balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted average exercise price, Options cancelled/forfeited Weighted average exercise price, option outstanding, granted Weighted average exercise price, option outstanding, Ending balance Grant under 2016 Plan [Member] Warrants,Weighted average exercise price, Options cancelled/forfeited Stock Options 1999 Plan [Member] Number of shares, Options Outstanding Options cancelled Weighted average exercise price, Options cancelled Award Type Axis Award Date Axis Series A Stock [Member] May 2022 Warrants [Member] May 2022 Offering [Member] Pre-Funded Warrants [Member] Inducement Stock Options [Member] August 2024 Private Placement Financing [Member] Warrants [Member] August 2024 Warrants [Member] 2016 Stock Incentive Plan [Member] Chief Medical Officer [Member] Second Inducement Stock Options [Member] First Inducement Stock Options [Member] February 2023 Offering [Member] February 2024 Offering 1 [Member] February 2023 [Member] February 2024 [Member] Amended 1999 Stock Plan [Member] Underwritten offering Pre-funded Warrants, Fair Value Convertible preferred stock, par value Exercise price Common Stock, Shares Authorized Class of Warrant or Right, Outstanding Issuance of preferred shares Preferred stock, par value Class of Warrant or Right, Outstanding Number Of Shares Previously Authorized For Issuance Common Stock, Par Value Common Stock, Shares Outstanding Common Stock, Shares issued Number Of Shares Of Common Stock Authorized For Issuance Warrant To Purchase Of Unregistered Common Stock Warrant To Purchase share of Common Stock Common stock shares Warrnat purchase Issued unregistered warrants to purchase shares of common stock Issuance of common stock shares Offering Price Common stock warrant Gross proceeds form warrant Agent fees and direct offering expenses Fair value allocated Purchase price Pre-funded warrants Shares Warrant Preferred Stock convertible into share of common stock Estimated fair value Stock issued during period, shares Proceeds From Issuance Of Private Placement Warrant To Purchase Of Unregistered Common Stock, Value Unrecognized Compensation Costs No compensation expense for stock option grants Stock Options Granted, Vesting Period Compensation Expense Stock Option Award Granted Stock Options Description Estimated Fair Value Of The Inducement Stock Option Award Granted Risk-free interest rate Dividend Yield Volatility Factor Rate Expected Life Subsequent Event Type [Axis] Subsequent Event [Member] Number of shares of common stock authorized for issuance Custom Element.